Form 4: Eli Lilly Executive Daniel Skovronsky Reports Share Transfers

Eli Lilly executive Daniel Skovronsky reported the transfer of company shares through gifts, including to a family trust and his spouse.

Summary

• Daniel Skovronsky, an executive at Eli Lilly, filed a Form 4 detailing changes in his beneficial ownership of company stock.
• On September 10, 2024, he gifted 111 shares of Eli Lilly common stock.
• On September 11, 2024, he gifted an additional 5,724 shares of Eli Lilly common stock.
• These gifts included 2,359 shares to DMGCS Family Holdings LLC, a trust controlled by his spouse, and 3,257 shares directly to his spouse.
• Following these transactions, Skovronsky directly owns 117,903 shares and indirectly owns 72,359 shares through a trust and 3,257 shares through his spouse.
• The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Sentiment

Score: 5

Explanation: The document is a neutral report of stock transfers, with no inherent positive or negative sentiment.

Management Comments

• The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Industry Context

This is a routine filing related to executive stock transactions and is common for publicly traded companies.

Comparison to Industry Standards

• Form 4 filings are standard practice for corporate insiders at publicly traded companies like Eli Lilly.
• These filings are required by the SEC to ensure transparency in insider trading activities.
• Similar filings are made by executives at other pharmaceutical companies such as Pfizer (PFE) and Johnson & Johnson (JNJ) when they engage in stock transactions.

Related Party Transactions

• The transfer of shares to a family trust and to the reporting person's spouse are considered related party transactions.

Stakeholder Impact

• The transactions do not have a direct impact on stakeholders, as they are personal transactions of an executive.
• The filing provides transparency to shareholders regarding executive stock ownership.

Key Dates

Keywords

Form 4, Beneficial Ownership, Stock Transfer, Executive, Eli Lilly, LLY, Daniel Skovronsky, Share Gift, Family Trust